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Abstract
Autophagy is a conserved degradative pathway used as a host defense mechanism against intracellular pathogens.
However, several viruses can evade or subvert autophagy to insure their own replication. Nevertheless, the molecular details
of viral interaction with autophagy remain largely unknown. We have determined the ability of 83 proteins of several
families of RNA viruses (Paramyxoviridae, Flaviviridae, Orthomyxoviridae, Retroviridae and Togaviridae), to interact with 44
human autophagy-associated proteins using yeast two-hybrid and bioinformatic analysis. We found that the autophagy
network is highly targeted by RNA viruses. Although central to autophagy, targeted proteins have also a high number of
connections with proteins of other cellular functions. Interestingly, immunity-associated GTPase family M (IRGM), the most
targeted protein, was found to interact with the autophagy-associated proteins ATG5, ATG10, MAP1CL3C and SH3GLB1.
Strikingly, reduction of IRGM expression using small interfering RNA impairs both Measles virus (MeV), Hepatitis C virus
(HCV) and human immunodeficiency virus-1 (HIV-1)-induced autophagy and viral particle production. Moreover we found
that the expression of IRGM-interacting MeV-C, HCV-NS3 or HIV-NEF proteins per se is sufficient to induce autophagy,
through an IRGM dependent pathway. Our work reveals an unexpected role of IRGM in virus-induced autophagy and
suggests that several different families of RNA viruses may use common strategies to manipulate autophagy to improve
viral infectivity.
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Introduction
Macroautophagy (thereafter referred to as autophagy) is a
highly regulated self-degradative mechanism for intracellular
clearance and recycling of cytoplasmic contents [1]. During this
process large portions of the cytoplasm are engulfed into
autophagosomes that subsequently fuse with lysosomes to form
acidic autolysosomes where degradation occurs. The autophagy
process results from a cascade of reactions orchestrated by
autophagy-related genes (atg) encoding ATG proteins mostly
defined in yeast and for which numerous mammalian orthologs
have been identified [2]. However, the function of most of these atg
remains poorly characterized and several non atg mammalian
genes were also described to regulate autophagy. During
autophagy, the formation of an isolation membrane is initiated
by class III phophatidylinositol 3-kinase (PIK3C3)/Beclin1
containing complexes [3–5]. The elongation of the isolation
membrane involves two ubiquitin-like conjugation systems [6,7].
In one of them, ATG12 associates with ATG5 for the formation of
ATG12-ATG5-ATG16L1 molecular complexes that bind the
outer membrane of the isolation membrane. In the second, LC3 is
coupled with phosphatidylethanolamine to generate a lipidated
LC3-II form that is integrated in both the outer and inner
membranes of the autophagosome.
Whereas required at a basal level for cellular homeostasis
maintenance, autophagy is used as a universal innate cell defense
mechanism to fight intracellular pathogens allowing their delivery
to degradative lysosomes [8,9]. Studies involving overexpression or
knock-down of atg have demonstrated an important role for
autophagy in both innate antibacterial [10–12] and antiviral
defense [13,14]. Autophagy contributes to immune surveillance
via cytoplasmic sampling and delivery of intracellular pathogens or
components of these pathogens to endosomes and major
histocompatibility complex (MHC)-II molecules rich compart-
ments, thus promoting innate recognition by endosomal Toll-like
receptors (TLR) [15] and pathogen-adaptive immune response
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pathway, intracellular pathogens were submitted to an evolution-
ary pressure that led to the selection of pathogens with different
molecular strategies to avoid or subvert this process to their own
benefit [8].
RNA viruses include several viral species that are of major
concerns in public health such as Hepatitis C virus (HCV), human
immunodeficiency virus 1 (HIV-1), influenza A, Measles virus
(MeV) or Dengue virus. These viruses dispose of a limited number
of viral proteins to control major cellular pathways such as protein
production or degradation, cell survival and evasion from host cell
defense. Several RNA viruses have been shown to subvert
autophagy, nevertheless few viral molecular adaptations to host
autophagy have been identified [19–25]. HIV-1 and influenza A
are two viruses that block autophagosome maturation. It has been
shown that both HIV-1-NEF and influenza A-M2 proteins target
Beclin1 to prevent autolysosome formation [21,24]. The identi-
fication of new viral factors able to physically interact with
autophagy-associated proteins and the characterization of their
functional consequences on autophagy might provide insights on
the strategies used by RNA viruses to manipulate and/or subvert
this pathway.
The growing knowledge of the molecular partners underlying
the execution and the regulation of the autophagy process
prompted us to analyze whether this machinery is particularly
targeted by RNA viruses. Using a yeast two-hybrid approach and
bioinformatics analysis, we have determined how proteins from 5
different RNA virus families (Paramyxoviridae, Flaviviridae, Orthomyx-
oviridae, Togaviridae and Retroviridae) physically interact with host
autophagy-associated proteins. We have found that autophagy is a
functional network highly targeted by RNA virus proteins. In
particular, we observed that IRGM is able to interact with proteins
from 5 different RNA virus families. Although IRGM was
previously reported to play an autophagy-dependent anti-bacterial
function [26,27], the mechanisms underlying the role of IRGM in
autophagy remain poorly understood [27–29]. We found that this
protein interacts with several key proteins of the autophagy
process. Furthermore, we describe a role of IRGM in both virus-
dependent autophagy induction and virus production. Our results
suggest that different RNA virus families have a conserved way to
overcome the host autophagy pathway in order to lead to a
successful infection.
Results
RNA viruses interact with multiple autophagy-associated
proteins
To gain an insight on the molecular mechanisms by which RNA
viruses modulate the autophagy process, we tested whether viral
proteins belonging to various strains of 5 different viral families
(Paramyxoviridae, MeV, Mumps virus, Nipah virus; Flaviviridae,
HCV, Dengue virus, West Nile virus, Tick borne encephalitis virus
and Kyasanur forest disease virus; Orthomyxoviridae, Influenza A
virus; Retroviridae, HIV-1; Togaviridae, Chikungunya virus) were able
to physically interact with human autophagy proteins. We
established a list of 44 autophagy-associated proteins closely
involved in human autophagy, based on data available from the
literature showing the functional involvement of the proteins in
autophagy using either short interfering (si)-RNA shutting down
the expression of the considered protein or protein overexpression
(Figure 1A and Table S1). Proteins that despite their crucial
involvement in autophagy are broad signalling regulators of
different cellular pathways were not included in our study. From
this list 35 autophagy-associated proteins (Figure 1A in blue and
Table S2) were available to be tested pairwise in a yeast two-
hybrid array against 80 different viral proteins (Table S3). We
found 42 new protein-protein interactions (ppi) between viral
proteins and autophagy-associated proteins to which were added
the 10 ppi between RNA virus proteins and autophagy-associated
proteins described in the literature (Figure 1B and Table S4). We
further tested the ability of IRGM, GOPC and SQSTM1, the
most common RNA virus targets, to interact with three different
HIV-1 proteins (Table S3/S4). Overall, among the 17 different
autophagy-associated proteins we found to be targeted by RNA
virus proteins, 9 proteins interact with one RNA virus family, 5
interact with 2 different families (BECN1, BCL2, UVRAG,
ATG5, BNIP3), 2 interact with 3 different RNA virus families
(SQSTM1 and GOPC) and one autophagy-associated protein,
IRGM, is a common target of 5 different families of RNA viruses
(Paramyxoviridae, Flaviviridae, Orthomyxoviridae, Togaviridae, Retroviridae)
(Figure 1B, Figure S3 and Table S4).
RNA viruses target human autophagy-associated
proteins that form a highly interconnected protein
network
Here, our results show that RNA virus proteins interact with
more than 35% of the autophagy-associated proteins suggesting
that autophagy is a widely targeted functional network. This
targeting is highly significant as compared to the targeted human
proteome counterpart (exact Fisher test, p value ,2,2610
216).
Nevertheless, a defined protein may play important roles in several
cellular functions; therefore a viral interaction with a particular
autophagy protein does not preclude an effect in a precise
pathway. To understand whether the proteins targeted by RNA
viruses are particularly dedicated to the autophagy process or may
be important to connect this conserved cellular function to other
cellular processes, we have established a comprehensive map of
ppi between the 44 autophagy-associated proteins (Figure 1C,
each node represents one autophagy-associated protein). We first
determined this network by systematically testing pairwise 35
autophagy-associated proteins (proteins in blue in Figure 1A) in a
Author Summary
Autophagy is a highly regulated cellular degradative
pathway for recycling of long-lived proteins and damaged
organelles. Autophagy is also used by host cells as a
defense mechanism against intracellular pathogens. Au-
tophagy can degrade pathogens or pathogen-derived
molecules trapped within specialized vesicles named
autophagosomes. Viruses and viral proteins are not an
exception. However, since autophagy is a conserved
pathway, viruses were submitted to an evolutionary
pressure that led to the selection of molecular strategies
which avoid or subvert this process to promote viral
replication. Nevertheless the molecular details of viral
interaction with autophagy remain largely unknown. We
determined the ability of 83 proteins of several families of
RNA viruses (including Hepatitis C virus (HCV), human
immunodeficiency virus 1 (HIV-1), Measles virus (MeV) and
influenza A virus) to interact with 44 human proteins
known to regulate autophagy and found that autophagy is
highly targeted by RNA viruses. Strikingly, immunity-
associated GTPase family M (IRGM), known for its role in
autophagy against bacteria, is the most targeted autoph-
agy protein. Its absence is detrimental for HCV, HIV-1 and
MeV production. Therefore, our data show that different
RNA viruses families use similar strategies to fine tune
autophagy to their own benefit.
RNA Viruses Target the Autophagy Network
PLoS Pathogens | www.plospathogens.org 2 December 2011 | Volume 7 | Issue 12 | e1002422yeast two-hybrid array and incremented our own set of data with
those from the literature to build the autophagy network [30]
(Figure 1C, Table S5). Overall, the human autophagy network is
composed of a total of 150 ppi, among them we identified 23 novel
intra-autophagy network interactions (Figure 1C, blue edges).
Interestingly, the human autophagy network appears as a highly
interconnected cellular network, with a single connected compo-
nent of 40 proteins, and only four isolated proteins (ATG4D,
ATG9A, WIPI1 and HDAC6) for which to date no protein
interaction was identified within the network. This interconnec-
tivity is significantly higher than the theoretical interconnectivity
computed from resampled subnetworks (resampling test,
n=10000, p value ,10
24, Figure S1). This high significance
supports the functional consistency of the initially chosen group of
44 autophagy-associated proteins.
An important fraction of autophagy-associated proteins
are both central to the autophagy network and highly
connected to other cellular pathways
The 44 proteins of the autophagy network do not function in
isolation but interact with roughly at least 450 other cellular
proteins within the whole human protein interaction network [30].
To analyze the relative functional contribution of each of the 44
autophagy-associated proteins to the autophagic process without a
priori, we determined their respective connectivity and centrality
Figure 1. Targeting of the autophagy network by RNA viruses. (A) List of the 44 autophagy-associated proteins considered in this study.
Proteins represented in blue were used in yeast two-hybrid arrays. (B) Autophagy-associated proteins are targeted by RNA viruses. Graphical
representation of ppi network of autophagy proteins and RNA virus proteins. Red nodes represent autophagy-associated proteins. Dark grey nodes
represent RNA viral families. Blue edges represent novel ppi and gray edges represent ppi retrieved from the literature. The width of the red nodes is
proportional to the number of viral families targeting the autophagy-associated proteins. (C) RNA viruses targeted human autophagy network.
Graphical representation of the targeted human autophagy network. Each node represents one autophagy-associated protein. Black nodes are
autophagy-associated proteins with unknown RNA virus interactions and red nodes represent autophagy-associated proteins targeted by at least one
RNA virus protein. Blue edges represent novel ppi and gray edges represent ppi retrieved from the literature. The width of the nodes is proportional
to the number of autophagy-associated proteins directly interacting with the considered protein.
doi:10.1371/journal.ppat.1002422.g001
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protein interaction network (Figure 2A and Table S6) [31]. The
connectivity or degree of a protein is the number of direct
interacting partners of this protein We have defined the autophagy
context-dependent connectivity as the ratio of the protein
connectivity within the autophagy network over those within the
whole human protein interaction network [31] (Figure 2A and
Figure S2A). This highlights 10 different proteins that have more
than two thirds of their interactions inside the autophagy network,
suggesting that they might be particularly dedicated to the
autophagy network (Figure 2A, x axis.0.66). Examples include
several different ATGs (ATG3, ATG4A/B, ATG7) but also
BNIP3 and IRGM. Interestingly, half of the autophagy-associated
proteins have less than one third of their interactions within the
autophagy network i.e. are essentially connected outside this
network (Figure 2A, x axis,0.33). Examples include BCL2,
ATG5, ATG12 or BECN1, indicating that an important fraction
of autophagy-associated proteins might be involved in the crosstalk
between autophagy and other cellular pathways.
Although the number of connections of a protein is relevant, the
flux of information passing through this protein, illustrated by its
centrality or betweenness, is another critical parameter that
determines the influence of a protein in a network. We have
defined the autophagy context dependent-centrality as the ratio of
the protein betweenness within the autophagy network over those
withinthewholehumanproteininteractionnetwork[31](Figure2A
and Figure S2B). Interestingly, most of the 44 autophagy-associated
proteins appear as essential components of the autophagy system
(Figure 2A, y axis.1). Among them were found most of the ATGs,
ULK1, BECN1, AMBRA1, PIK3C3 and PIK3R4, BNIP3 and
IRGM that exhibit increased betweenness values in the autophagy
network compared to the whole human interactome.
IRGM is highly targeted by RNA viruses
Our results show that RNA viruses mainly target proteins that
although central to this functional network connect autophagy to
other cellular functions (Figure 2A, y axis.1, targeted proteins
represented in red). Indeed, with the exception of three proteins
(IRGM, BNIP3 and TMEM74), all RNA virus-targeted autoph-
agy-associated proteins have more than 60% of their interactions
that take place out of the autophagy network (Figure 2A, x
axis,0.4 targeted proteins represented in red). Strikingly, IRGM
is noteworthy by being commonly targeted by 5 different families
of RNA viruses (Figure 1B and Figure S4) and by making all its
cellular protein interactions within the autophagy network
(Figure 2). These results prompted us to investigate whether
IRGM and the autophagy interactors we identified by yeast two-
hybrid (Figure 2B) could associate in mammalian cells. In co-
transfected human HeLa cells, we first found that IRGM co-
localizes with ATG10, ATG5, SH3GLB1 and MAP1LC3C
(Figure 2C). Furthermore, physical interactions between IRGM
and each of these autophagy-associated proteins were confirmed
by GST-co-affinity experiments in human cells (Figure 2D). We
found that endogenous IRGM colocalizes with endogenous
SH3GLB1 and ATG5 (Figure 2E), and that a small fraction of
endogenous ATG5 interacts with overexpressed IRGM but not
with SQSTM1 (Figure 2F and Figure S5). Together, our results
show that IRGM can interact with several autophagy-associated
proteins.
Autophagosome formation during MeV, HCV and HIV-1
infections depends on IRGM
IRGM being both particularly targeted by RNA viruses and
interacting with several autophagy-associated proteins, prompted
us to test whether this protein was involved in virus-induced
autophagy. We have found that IRGM interacts with MeV
(Paramyxoviridae family), HCV (Flaviviridae family), influenza A
(Orthomyxoviridae family) and HIV-1 (Retroviridae family) proteins
(Figure 1B, Figure S4 and Table S4), four viruses described to
induce autophagosome accumulation upon infection
[19,21,24,32]. To determine whether IRGM is involved in
autophagosome formation observed upon MeV, HCV and
influenza A infections we have abrogated IRGM expression using
specific si-RNA (Figure S6A–G), prior to infection in GFP-LC3-
HeLa cells, GFP-LC3-Huh 7.5 or GFP-LC3-A549 cells, respec-
tively. IRGM mRNA (Figure S6F) and endogenous protein
(Figure S6C–E, G) was detected in cell lines used in our studies.
The level of expression of the endogenous protein is specifically
decreased in cells treated with si-IRGM (Figure S6D/E), as
previously observed [28].
Autophagosomes were monitored by tracking the formation of
GFP-LC3-labelled structures representing LC3-II-containing au-
tophagosomes. The reduced expression of ATG5 induced by si-
RNA was used as a control for autophagy extinction (Figure S7).
First, we found that the reduced expression of IRGM did not
significantly modulate ongoing autophagy in each tested cell line
(Figure 3A/B, D/E, G/H). Second, as previously reported, we
found upon MeV (Figure 3A/B), HCV (Figure 3D/E) and
influenza A (Figure 3G/H) infections an increased number of
autophagosomes. Interestingly, the inhibition of expression of
either IRGM or ATG5 prevented the increase of autophagosomes
induced by MeV and HCV (Figure 3A/B/D/E). However,
contrarily to the reduced expression of ATG5, the inhibition of
expression of IRGM did not prevent significantly autophagosome
accumulation upon influenza A infection (Figure 3G/H).
We further tested the requirement of IRGM on MeV, HCV,
influenza A and HIV-1-dependent autophagy modulation by
monitoring the conversion of LC3-I (cytosolic form) to LC3–II
(autophagosome-bound lipidated form) by western blot in HeLa,
Huh 7.5, A549 cells and human monocyte-derived macrophages
(MDM), respectively. Without infection, we found that si-IRGM-
treated cells do not display modulation of the total amount of LC3-
II when compared to si-control treated cells (Figure 3C/F/I/J).
We next found that MeV infection did not lead to an increased
amount of LC3-II in si-control treated cells but instead a decrease,
when compared with uninfected si-control-treated cells. This
results might be the consequence of the increase of the autophagy
flux induced upon MeV infection leading to the formation of
productive autolysosomes, as we already reported [32]. Neverthe-
less, diminished IRGM expression reduced MeV-induced LC3-II
amount, similarly to si-ATG5 treatment (Figure 3C). HCV,
influenza A and HIV-1 were all reported to inhibit autophago-
some maturation [21,24,33]. We found that infection with these
viruses lead to an increased amount of LC3-II, when compared to
uninfected cells. Moreover, the diminished expression of IRGM
reduced HCV and HIV-1-increased LC3-II amount, similarly to
si-ATG5 treatment (Figure 3F/J), whereas it has no effect on
influenza A infection (Figure 3I).
Finally, we determined autophagy modulation during MeV,
HCV, influenza A and HIV-1 infections in the presence of
bafilomycin A1 (BAF), which inhibits acidification of the
autolysosomes (Figure S8). We found that upon BAF treatment
the total number of GFP-LC3 dots in MeV-infected cells was
further increased when compared with untreated MeV-infected
cells, and no further increased was observed upon HCV or
influenza A infections (Figure S8A–F). Upon HIV-1 infection a
slight increase of the total amount of LC3-II was detected in BAF-
treated cells when compared with uninfected cells (Figure S8G).
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PLoS Pathogens | www.plospathogens.org 4 December 2011 | Volume 7 | Issue 12 | e1002422Figure 2. IRGM, a protein that is highly targeted by RNA viruses, co-localizes and interacts with several autophagy-associated
proteins. (A) Autophagy-associated proteins contribute differently to the autophagy network. Autophagy-associated proteins are plotted according
to their context connectivity and context centrality. Autophagy context connectivity (x axis) is the ratio of interaction in autophagy network over the
interaction in the whole human protein interaction network. Autophagy context centrality (y axis) is the ratio of betweenness (log normalized values)
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accumulation of autophagosomes upon MeV, HCV or HIV-1
infections, but not upon influenza A virus infection in BAF-treated
cells (Figure S8).
Thus, altogether these results indicate that IRGM is involved in
MeV, HCV and HIV-1-mediated autophagosome accumulation.
IRGM modulates MeV, HCV and HIV-1 infectious particle
formation
We next evaluated whether IRGM could modulate MeV, HCV,
influenza A and HIV-1 infectious particle formation. To this end,
we have impaired IRGM expression by si-RNA, infected HeLa
cells, Huh 7.5 cells, A549 cells or human MDM with the
appropriate viruses and evaluated its effect on viral particle
formation. Looking at MeV infectivity, we first found that shutting
down the expression of the autophagy essential gene ATG5
impaired the production of infectious particles by more than
65%, indicating that MeV hijacks autophagy to its own benefit
(Figure 4A). Importantly, MeV infectious particle production was
equally compromised in absence of IRGM expression (Figure 4A).
Similar results were obtained concerning HCV infectivity for which
the involvement of autophagy in the formation of viral particles was
previously reported [20]. Interestingly we found that the absence of
IRGM compromised the production of infectious HCV particles by
more than 70%, similarly to the absence of ATG5 (Figure 4B). In
contrast,thereduced expressionofIRGMdoesnot impairinfluenza
A particle production (Figure 4C). Down regulation of ATG5 has
also no influence on the viral production, as previously reported
[21]. Finally, it was recently shown that autophagy modulates HIV
production inhumanMDM[24,34].Wefoundherethat absenceof
IRGM compromised the production of HIV-1 particles by more
than 30%, similarly to the reduced expression of ATG5 (Figure 4D).
Overall our results show that IRGM is involved in the production of
viral particles of at least three different RNA viruses, MeV, HCV
and HIV-1.
MeV-C, HCV-NS3 and HIV-NEF proteins interact with
IRGM and induce autophagosome accumulation via a
molecular process involving this protein
To get a deeper insight on the molecular mechanisms
underlining IRGM’s role in both virus induced autophagy and
viral particle formation we have first analysed whether IRGM and
its putative viral MeV, HCV or HIV interactors could associate in
human cells. In co-transfected human HeLa cells, we found that
IRGM co-localizes with MeV-C, HCV-NS3 and HIV-NEF,
(Figure 5A). Furthermore, we confirmed the physical interaction
between IRGM and MeV-C, HCV-NS3 and HIV-NEF using
GST-co-affinity experiments (Figure 5B). Thus IRGM interacts
with proteins from several different RNA virus families.
We then determined whether the viral proteins able to interact
with IRGM, could modulate autophagosome formation. To this
end, MeV-C, HCV-NS3 or HIV-NEF were expressed in GFP-
LC3-HeLa cells and autophagy analyzed by tracking GFP+
autophagosomes. We found that each of these viral proteins
induced a significant increase of the number of autophagosomes
compared to the overexpression of GST, used as a control
(Figure 6A/B). Importantly, impairment of IRGM expression
leads to a decrease of the number of autophagosomes observed
upon overexpression of each of the three viral proteins, as the
reduced expression of ATG5 (Figure 6C/D/E/F). Thus, our
results show that the MeV-C, HCV-NS3 and HIV-NEF proteins
promote autophagosome accumulation via a molecular process
involving IRGM.
Discussion
Interactome RNA viruses/autophagy
We found that the autophagy network is highly and significantly
targeted by RNA viruses suggesting that this cellular process plays
an important role in virus biology. Our data suggest that RNA
viruses target proteins that although central to autophagy also
present a high number of physical connections with proteins
involved in other cellular functions. A recent analysis of the global
organization of the autophagy network revealed that this
conserved cellular function is connected to other cellular functions
such as proteolysis, signal transduction, phosphorylation and
vesicle transport [35]. Thus, molecular bridges between autophagy
and other cellular functions might be preferentially targeted by
RNA viruses. The ability to manipulate multifunctional proteins
might empower RNA viruses with the ability to fine-tune different
complementary cellular functions which are necessary for
successful virus infection and replication. A major challenge
remains to determine how these viral/cellular protein interactions
translate into functional changes imposed by RNA viruses on
autophagy and/or other connected cellular functions.
Interaction between viral proteins and autophagy-associated
proteins can be explained either by a viral adaptation to this
cellular function or alternatively autophagy-associated proteins
might be devoted to detection/binding of pathogen proteins to
promote anti-viral function. For instance, SQSTM1 (also called
p62) brings cargos of ubiquitinated proteins to autophagy
in autophagy network over the betweenness in the human protein interaction network. A protein with high degree and high betweenness ratios is
respectively defined as highly devoted and highly central in the autophagy context. Proteins in red represent autophagy-associated proteins targeted
by at least one RNA virus protein. The four proteins that are not connected to the autophagy network are not represented. (B) IRGM interacts with
ATG10, ATG5, SH3GLB1 and MAP1LC3C. IRGM was tested by yeast two-hybrid against 35 different autophagy-associated proteins. Positive
interactions with ATG10, ATG5, SH3GLB1 and MAP1LC3C were found. A reduced yeast two-hybrid matrix containing positive interactions and the
appropriate empty vector controls is shown. One experiment representative of three is shown. (C) IRGM co-localizes with autophagy-associated
proteins. GFP-IRGM was expressed in HeLa cells together with FLAG-ATG10, FLAG-ATG5, FLAG-SH3GLB1 or FLAG-MAP1LC3C. Fixed cells were then
stained with an anti-FLAG antibody and GFP-IRGM and FLAG-tagged proteins co-localisation was visualized on merged images by confocal
microscopy. Scale bars, 5 mM. (D) IRGM interacts with autophagy-associated proteins. HEK293T cells were co-transfected with GST and GST-tagged
expression vectors encoding the indicated proteins and FLAG-IRGM. Interaction was assayed by co-affinity purification (AP) using glutathione-
sepharose beads. FLAG-IRGM was detected using anti-FLAG antibody after (AP-GST, WB: FLAG) and before (total cell lysate-TCL, WB: FLAG) co-AP. GST
alone and GST-tagged proteins were detected by using anti-GST antibody (AP-GST, WB: GST). One experiment representative of two is shown. (E)
Endogenous IRGM co-localizes with endogenous SH3GLB1 and ATG5 in MeV infected cells. HeLa cells were infected with MeV Edmonston (MOI=1)
for 24 hrs. Cells were fixed in acetone and both IRGM and/or SH3GLB1 or ATG5 were detected using specific antibodies. IRGM/SH3GLB1 or IRGM/
ATG5 protein co-localisation was visualized on merged images obtained by confocal microscopy. Scale bars, 5 mM. (F) Endogenous ATG5 interacts
with FLAG-IRGM. HeLa cells were transfected or not with FLAG-IRGM encoding vector and infected with MeV (MOI=1) 24 hrs post-transfection. Cells
were lysed 24 hrs post-infection. Flag-tagged IRGM was immunoprecipitated and endogenous ATG5 binding was detected by western blot (top
panel). Overexpression and immunoprecipitation of FLAG tagged IRGM was confirmed by a western blot using (bottom panel).
doi:10.1371/journal.ppat.1002422.g002
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PLoS Pathogens | www.plospathogens.org 6 December 2011 | Volume 7 | Issue 12 | e1002422Figure 3. MeV, HCV and HIV-1-induced autophagosome accumulation is dependent on IRGM. (A–C) MeV-induced autophagy is
dependent on IRGM. GFP-LC3-HeLa (A–B) or HeLa cells (C) were treated with si-control, si-ATG5 or si-IRGM and either left uninfected or infected with
MeV Edmonston (MOI=3) for 24 hrs. Autophagy was monitored either by evaluating the number of GFP-LC3+ vesicles per cell profile by confocal
RNA Viruses Target the Autophagy Network
PLoS Pathogens | www.plospathogens.org 7 December 2011 | Volume 7 | Issue 12 | e1002422microscopy (A, B) or by detection of LC3-I and LC3-II by western-blot (C). Representative profiles for each condition (A) and the corresponding graph
representing the number of GFP-LC3+ vesicles per cell profile (B) are shown, error bars, mean 6 SD of three independent experiments. (C) One
experiment representative of three is shown. (D–F) HCV-induced autophagy is dependent on IRGM. GFP-LC3-Huh7.5 (D–E) or Huh7.5 (F) cells were
treated with the indicated si-RNA and either left uninfected or infected with HCV JFH-1 (MOI=1) for 24 hrs. Autophagy was monitored as above. (E)
Error bars, mean 6 SD of three independent experiments. (F) One experiment representative of two is shown. (G–I) Influenza A-induced autophagy is
not impaired by IRGM absence. GFP-LC3-A549 (G–H) or A549 (I) cells were treated with the indicated si-RNA and either left uninfected or infected
with influenza A/H1N1/New Caledonia (MOI=1) for 24 hrs. Autophagy was monitored as above. (H) Error bars, mean 6 SD of two independent
experiments. (I) One experiment representative of two is shown. (J) HIV-1-induced autophagy is dependent on IRGM. Monocyte-derived
macrophages (MDM) were treated with the indicated si-RNA and were either left uninfected or infected with HIV-1 for 24 hrs. LC3-I and LC3-II
detection was carried out by western-blot as in C, F, I. One experiment representative of two is shown with the quantification number representing
the intensity of LC3-II/GAPDH bands normalized to the uninfected condition. Student’s t test; * p,0.05; ** p,0.01; # p.0.05.
doi:10.1371/journal.ppat.1002422.g003
Figure 4. IRGM reduced expression efficiently decreases MeV, HCV and HIV-1 viral particles production. (A) IRGM is necessary for MeV
infectious particle production. HeLa cells were treated with the indicated si-RNAs. Cells were infected with MeV (MOI=3) for 24 or 48 hrs. Results
display average total infectious titers expressed as plate-forming units (pfu)/ml. Error bars, mean 6 SD of three independent experiments. (B) IRGM is
required for HCV JFH-1 infectious particle production. Huh-7.5 cells were treated with the indicated si-RNAs prior to cell infection with HCV JFH-1
(MOI=1). The infectivity of the virus-containing cell supernatants was determined at 24 and 48 hrs post-infection. Results display average infectious
titers. Error bars, mean 6 SD of respectively three (24 hrs) or two (48 hrs) independent experiments. (C) IRGM-reduced expression does not modulate
influenza A infectious particle production. A549 cells were treated with the indicated si-RNAs prior to cell infection with Influenza A/H1N1/New
Caledonia (MOI=0.1). The infectivity of the virus-containing cell supernatants was determined at 24 hrs post-infection. Results display average
infectious titers. Error bars, mean 6 SD of two independent experiments. (D) IRGM-reduced expression modulates HIV-1 production. MDM were
treated with the indicated si-RNAs prior to cell infection with HIV-1. The infectivity was determined at 24 hrs post-infection. Results correspond to one
experiment in triplicate, representative of four independent experiments. Student’s t test; * p,0.05; ** p,0.01; # p.0.05.
doi:10.1371/journal.ppat.1002422.g004
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against Sindbis virus infection by promoting autophagy-dependent
but ubiquitination-independent capsid protein degradation [13].
We found here that SQSTM1 has a potential to bind proteins of at
least 3 different families of human-infecting RNA viruses. Whether
these interactions act in the host cellular defense or are viral
subversive pathways has to be tested in specific virus/host cell
contexts. GOPC is another highly targeted autophagy-associated
protein. However, GOPC appears to be poorly dedicated to
autophagy suggesting that its targeting might essentially affect non-
autophagy cellular processes.
Only two highly autophagy-dedicated proteins were found to
interact with RNA virus proteins, BNIP3 and IRGM. Another
targeted autophagy-associated protein, TMEM74 is exclusively
connected to the autophagy network, since we found it interacts
with BNIP3. BNIP3 and TMEM74 are involved in stress-induced
autophagy regulation [37,38]. Interestingly we found that BNIP3
is able to interact with a large number of proteins within the
autophagy network acting at different steps of the autophagic
process. This suggests that under specific conditions this protein
might allow the coordination and the concerted action of di-
fferent sub-networks necessary for autophagy progression/
inhibition. Whether BNIP3 and TMEM74 are effective during
viral infection is unknown, although they might both (co)-regulate
cellular responses to viral infection through autophagy
induction.
Figure 5. Co-localisation and physical interaction of IRGM with MeV-C, HCV-NS3 and HIV-NEF proteins. (A) IRGM co-localises with MeV-
C, HCV-NS3 and HIV-NEF. GFP-IRGM was expressed in HeLa cells together with FLAG-MeV-C or FLAG-HCV-NS3 or FLAG-HIV-NEF. Co-localisation
between GFP-IRGM and FLAG-tagged proteins was visualized as in figure 2B. Scale bars, 5 mM. (B) IRGM physically interacts with MeV-C, HCV-NS3 and
HIV-NEF. HEK-293T cells were co-transfected with expression vectors encoding FLAG-IRGM and GST alone or GST fused to the indicated viral proteins.
Co-purification of IRGM with viral proteins was assessed as in figure 2C. One experiment representative of two is shown.
doi:10.1371/journal.ppat.1002422.g005
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PLoS Pathogens | www.plospathogens.org 9 December 2011 | Volume 7 | Issue 12 | e1002422Figure 6. MeV-C, HCV-NS3 and HIV-NEF proteins modulate autophagy via IRGM. (A–B) Overexpression of MeV-C, HCV-NS3 and HIV-NEF
modulates autophagosome formation. (A–B) GFP-LC3 HeLa cells were transfected with a GST encoding vector (control) or a vector encoding MeV-C,
HCV-NS3 and HIV-NEF proteins. Twenty four hours post transfection the number of autophagic vesicles was determined by confocal microscopy.
Representative profiles for each condition (A) and the corresponding graph representing the number of GFP-LC3+ vesicles per cell profile (B) are
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by RNA viruses
We focused our functional work on IRGM since our data
support that this protein might be an important regulator of
autophagy. We would thus expect that the interaction of a viral
protein with IRGM might trigger a functional and specific effect
on this cellular function. Many immunity associated GTPases
(IRG) exist in mammals and these proteins play an important role
in defense against intracellular pathogens [39]. Only two IRG
exist in humans, IRGC and IRGM [40]. IRGM is a genetic risk
factor in Crohn’s disease and tuberculosis [41–43]. Human IRGM
is constitutively expressed, contrarily to its mouse homolog Irgm1,
and it was shown to regulate both IFN-c- and rapamycin-induced
autophagy in human macrophages [27]. Nevertheless the
molecular mechanism underlying its function in autophagy
remains poorly understood. A recent study reported a role of
IRGM in mitochondrial fission important for autophagic control
of intracellular mycobacteria [29]. Furthermore loss of tight
regulation of IRGM expression compromises the control of
intracellular replication of Crohn’s disease-associated adherent
invasive Escherichia coli by autophagy [28]. However, prior to our
study no molecular protein connection of IRGM with autophagy
has been reported. We found that IRGM is able to directly
interact with several autophagy proteins, whereas we did not find
any other IRGM interacting human proteins through a yeast two-
hybrid screen against a normalized human spleen cDNA library
(data not shown). IRGM molecular partners in the autophagy
network are involved in the initiation/elongation phases (ATG5,
ATG10, MAP1CL3C and SH3GLB1) suggesting that IRGM
would modulate the initial steps of autophagy. As previously
described [29], we found that IRGM is located in the
mitochondrial fraction (Figure S9). This suggests that IRGM
interactions with autophagy-associated proteins might take place
at the mitochondria, in initial phases of the autophagic process. At
least two of the potential IRGM interactors might be partially
located at the mitochondria under particular cellular contexts.
ATG5 was shown to be able to physical associate with a
mitochondria located protein IPS-1/MAVS [44]. Additionally, a
fraction of SH3GLB1 is located in the mitochondria and is
required for the maintenance of mitochondrial morphology
[45].
IRGM is known to play a protective role against bacterial
infection favoring IFNc-mediated autophagy elimination of
Mycobacterium bovis in macrophages [27] and anti-bacterial
autophagy responses in epithelial cells against Salmonella thyphymur-
ium [26] and adherent-invasive Escherichia coli [28,46]. However,
we found that in the context of RNA virus infections, IRGM does
not contribute to a protective role but instead promotes virus
replication. Virus/host co-evolution might have lead to subversion
of an initial protective mechanism initiated by IRGM/viral
protein interaction. Indeed, autophagy induction involving IRGM
is ultimately exploited by MeV, HCV and HIV-1 and favours viral
infectious particle production. Thus for viruses able to inhibit
autophagy maturation, additional molecular virus/autophagy
interaction would be necessary to block this specific step. In line
with this hypothesis, HIV was recently shown to inhibit
autophagosome maturation in 293T and we also found here that
HIV-1 may partially inhibit autophagosome maturation in human
MDM (Figure S8G). HIV-1-mediated inhibition of autophagy
maturation was described to involve HIV-NEF via its interaction
with BECN-1 [24]. HCV infection was also reported to prevent
autophagosome maturation at an early time of infection ([33] and
Figure S8C/D). Alternatively, viral proteins may specifically target
IRGM to promote autophagy. Importantly, IRGM-interacting
viral proteins MeV-C, HCV-NS3 and HIV-1-NEF, induce
autophagy in an IRGM-dependent pathway. Viral proteins might
facilitate IRGM interaction with its autophagy partners, by
facilitating its relocalization to or stabilization with autophagy-
associated proteins involved in the initiation phases of autophago-
some formation. Interestingly, the mouse IRGM homolog, Irgm1
was found to bind specific phosphoinositides, through a
carboxy (C)-terminal amphipathic helical segment, allowing
the recruitment of Irgm1 on nascent and early phagosomes
[47].
Although we found that IRGM can interact with influenza A
proteins, we found that its absence does not influence influenza A-
induced autophagy. Cell infection by influenza A was reported to
inhibit autophagy maturation, what we also observed using BAF-
treatment (Figure S8E/F) [21]. It is possible that interaction might
either not be engaged upon influenza A infection or be involved in
other not yet identified IRGM-associated cellular process.
Autophagy is a process that has the potential to degrade
pathogens or pathogen-derived molecules trapped within autop-
hagosomes. Viruses and viral proteins are not an exception.
Nevertheless its ability to promote cell survival under stress
conditions might be beneficial to virus since a major defense
mechanism against viral infection is cell death. Overriding this
mechanism can give rise to infected cell survival and further viral
spread. Furthermore autophagy might provide membranous
surfaces required for viral replication. Therefore the molecular
analysis of the interplay between viruses and autophagy as well as
of its consequences on viral and cellular biology might be of
importance to control viral infection. We highlight here and
unrevealed role of IRGM in autophagy subversion by RNA
viruses. Our semi-global interactome approach opens many doors
for a better understanding of the interplay between autophagy and
RNA viruses by suggesting many possible molecular targets of
RNA viruses among the autophagy-associated proteins.
Materials and Methods
Ethics statement
The experiments in this article were performed at Biological
Safety Level 2 and 3 in accordance with the regulations set forth
by the by the national French committee of genetic (commission
de ge ´nie ge ´ne ´tique). Venous blood from anonymous healthy
human volunteers was obtained from the blood bank (Etablisse-
ment Franc ¸ais du Sang) in accordance with its guidelines,
published in the French Journal Officiel, with informed written
consent from each volunteer.
Plasmids and Gateway cloning
All constructions were performed with a Gateway recombina-
tional cloning system (Invitrogen).
shown, error bars, mean 6 SD of three independent experiments. (C–F) MeV-C, HCV-NS3 and HIV-NEF modulate autophagosome formation partly via
IRGM. (C) GFP-LC3 HeLa cells were treated with si-control, si-ATG5 or si-IRGM 24 hrs prior transfection with vector encoding for MeV-C, HCV-NS3 or
HIV-NEF. After an additional 24 hrs, cells were fixed and the number of autophagosome was determined by confocal microscopy. Representative
profiles for each condition (C) and the corresponding graph representing the number of GFP-LC3+ vesicles per cell profile (D–F) are shown, error bars,
mean 6 SD of three independent experiments. Student’s t test; * p,0.05; ** p,0.01.
doi:10.1371/journal.ppat.1002422.g006
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Complete cDNA for 35 autophagy-associated proteins were
purchased from several providers (Table S2). Most cDNAs were
available in a pDONR vector (Gateway technology, Invitrogen).
For ATG4D, ATG9A, BECN1, IRGM and ULK1, a PCR
product containing attB sites was generated. Primers used in
Gateway cloning are available upon request. These attB-PCR
products were used in a BP recombination reaction (Invitrogen).
Viral ORFs
All 80 viral ORFs used are available in ViralORFfeome
ORFeotheque in a gateway pDONR vector [48] (Table S3). For
the HIV-1 ORFs NEF, VPR, VIF a PCR product containing attB
sites was generated.
Yeast two-hybrid array (autophagy vs autophagy and
viruses vs autophagy)
35 autophagy-associated cDNAs were transferred by in vitro
recombination from a pDONR into both pGBKT7 and pACT2.
These constructs were respectively transformed in both bait strain
AH109 (Clontech) and prey strain Y187 (Clontech). Viral ORFs
(baits) (Table S3) were transferred by in vitro recombination from a
pDONR into the yeast expression vector pGBKT7 and trans-
formed into the yeast bait strain AH109. Autophagy-associated
ORFs (prey) were transferred into pACT2 and transformed into
the yeast strain Y187. Yeast cells were mated and subsequently
plated on a selective medium lacking histidine to test the
interaction-dependent transactivation of the HIS3 reporter gene.
Protein-protein interaction from the literature
All binary interactions between human autophagy proteins were
extracted from the VirHostNet knowledge base and manually
checked in each original paper. Protein-protein interaction
network graphics were performed using the networks GUESS
tool (http://graphexploration.cond.org).
Networks metrics
The degree k of a node v in a graph G is the number of edges
that are incident to this node. The betweenness b of a node v in a
graph G can be defined by the number of shortest paths going
through the node v and is normalized by twice the total number of
protein pairs in the graph G (n*(n-1)). The equation used to
compute betweenness centrality, b(v), for a node v is:where gij is
the number of shortest paths going from node i to j, i and j, V and
gij(v) the number of shortest paths from i to j that pass through the
node v:
b(v)~
1
n|(n{1)
|
X
i,j,v[V
i=j=v
gij(v)
gij
Interconnectivity significance
The overall statistical significance of the observed autophagy-
associated proteins interconnectivity (number of protein-protein
interactions) was assessed by a random resampling testing
procedure (n=10,000 permutations).
Cells
HeLa and GFP-LC3-HeLa cells were maintained in RPMI
1640 supplemented with 0,5 mg/mL gentamicin, 2 mM L-
glutamine and 10% fetal calf serum. HEK293T, Huh7.5, GFP-
LC3-Huh7.5, A549, GFP-LC3-A549, Vero cells and MDCK were
maintained in DMEM supplemented with 0,5 mg/mL gentami-
cin, 10% fetal calf serum. Additionally Huh7.5 and Huh7.5-GFP-
LC3 were supplemented with 1% of non-essential amino acids.
Monocytes were purified from the blood of healthy human donors.
Human monocytes were cultured in RPMI 1640 supplemented
with 10% fetal calf serum and differentiated into macrophages
using 10 ng/mL of rh-M-CSF during 6 days (Immunotools,
Friesoythe, Germany).
Transfection
HEK293T cells were transfected using jetPEI (PolyPlus, Illkirch,
France) according to manufacturer’s instructions. HeLa, GFP-
LC3-HeLa, Huh 7.5, GFP-LC3-Huh 7.5 were transfected using
lipofectamine 2000 (Invitrogen). A549 and GFP-LC3-A549 were
reverse transfected using lipofectamine 2000.
Antibodies
Anti-Glutathione-S-Transferase (GST) peroxidase (A7340), anti-
FLAG M2 peroxidase (A8592), anti-MAP1LC3B (L7543), anti-
Actin (A2066), anti-Myc (C3956), anti-ATG5 (A0856) and anti-
eGFP (G6795) were from Sigma (St Louis, Mo, USA). Anti-IRGM
(NT) antibody PK-AB718-4543 was purchased from PromoKine
(Heidelberg, Germany) was used for immunofluorescence studies.
Anti-IRGM (ab93901) purchased from abcam (Cambridge, UK)
was used to detect IRGM by western blot. Anti-ATG5 mouse
monoclonal antibody clone 177.19 from Millipore was used to
detect endogenous ATG5 by immunofluorescence. Anti-
SH3GLB3 mouse monoclonal purchased from Sigma (St Louis,
Mo, USA) was use to detect endogenous protein by immunoflu-
orescence. Anti-cytochrome c mouse monoclonal was purchased
from BD Biosciences (Le Pont de Claix, France) and the anti-
GAPDH mouse monoclonal from Santa Cruz Biotechnology
(Santa Cruz, USA). Anti-rabbit HRP (NA 934) was from
Amersham Biosciences (Uppsala, Sweden). Anti-mouse Alexa
Fluor 568 and 488 was purchased from Invitrogen (Molecular
Probes).
Confocal microscopy
HeLa cells were co-transfected with GFP–IRGM and FLAG
tagged ATG10, ATG5, SH3GLB1, MAP1LC3C, MeV-C, HCV-
NS3 or HIV-NEF. After 24 h cells were fixed with 2%
paraformaldehyde stained using an anti-FLAG antibody followed
by secondary antibody conjugated to Alexa Fluor 568. For
endogenous IRGM detection by immunofluorescence, MeV
infected HeLa cells were fixed in cold acetone and IRGM was
detected using an anti-IRGM polyclonal antibody from Promo-
Kine (Heidelberg, Germany) followed by a secondary antibody
conjugated to Alexa Fluor 488. Endogenous ATG5 or SH3GLB1
were detected respectively using an anti-ATG5 mouse monoclonal
antibody clone 177.19 from Millipore or an anti-SH3GLB3 mouse
monoclonal from Sigma (St Louis, Mo, USA). Virus infected GFP-
LC3-expressing cells were fixed with 4% paraformaldehyde.
Bafilomycin A1 for flux experiments was purchased from Sigma
(St Louis, Mo, USA SIGMA). GFP-LC3 HeLa cells and GFP-LC3
A549 were treated for 5 hrs with 100 nM of bafilomycin while
GFP-LC3 Huh 7.5 cells were treated for 24 hrs. The number of
GFP
+ vesicles per cell profile was numerated from one single plan
section per cell. In each case, number of GFP
+ vesicules was
numerated from 100 to 200 cells for each experiment. All the cells
were analyzed using a Axiovert 100 M microscope (Zeiss,
Go ¨ttingen, Germany) equipped with the LSM 510 system (Zeiss)
and observed with a magnification of 636(oil immersion).
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1.5 mg of each expression vector were transfected in HEK293T
cells. Cell lysis was done 48 hrs post-transfection. Glutathione-
sepharose 4B beads (GE healthcare, Saint Cyr au Mont d’Or,
France) were used for the co-AP purification. For the indicated
experiments HEK293T cells were transfected with both pCi-neo-
3X FLAG and pDESTmyc expression vectors. Protein G
sepharose 4B beads coated with 1 mg of anti-Myc antibody were
used for a co-AP.
10610
6 HeLa cells were transfected or not with pCi-neo-3X
FLAG IRGM and infected with MeV (MOI=1) 24 hrs post-
transfection. Cells were lysed 24 hrs post-infection. Protein G
sepharose 4B beads coated with 1 mg of anti-FLAG mouse
monoclonal antibody were used for a co-AP of the FLAG tagged
IRGM. Endogenous ATG5 associated to FLAG-tagged IRGM
was detected using anti-ATG5 from Sigma (A0856).
Small interfering RNA experiments
Smartpool si-ATG5, si-IRGM and control si-RNA were from
Dharmacon (Perbio, Brebie `res, France). 1.10
5 HeLa, HeLa-GFP-
LC3, Huh 7.5, Huh 7.5-GFP LC3 cells were plated in 6-well plates
24 hrs prior to transfection with 100 rmol si-RNA using
Lipofectamine RNAiMAX (Invitrogen) according to manufactur-
er’s instructions. A549 cells and GFP-LC3-A549 were reverse
transfected. Human MDM were transfected with 3 mg of si-RNA
using Amaxa Human Macrophage Nucleofector Kit according to
manufacturer’s instructions.
Preparation of mRNA and cDNA synthesis
Total RNA was extracted from 10610
6 cells, isolated by using
total RNeasy isolation kit Qiagen and treated with DNAse (DNase
Ambion Turbo DNA free, Ambion) to remove genomic DNA
according to manufacturers instructions. Oligotex Direct mRNA
isolation kit (Qiagen) was used to isolate mRNA from total RNA
and cDNA was synthesized using mRNA (0.5 mg) by High
Capacity RNA-to-cDNA Master Mix (Applied BioSystems)
according to manufacturers instructions.
mRNA quantification
IRGM mRNA was quantified with a quantitative real-time
polymerase chain reaction (qRT-PCR). qRT-PCR reactions were
performed with the StepOnePlus Real-Time PCR System (Applied)
using the FastStart Universal SYBR Green Master (Rox) (Roche).
cDNA was synthesized using the mRNA from the cells as template,
and RT
2 qPCR Primer Assay for Human IRGM (Qiagen) was used.
The amount of measured transcripts was normalized to the amount
of the Ribosomal protein S9 transcript. Melting curve analysis was
performed after each run to analyse specificity of primers. We
assessed the presence of contaminating genomic DNA using a
minus-reverse transcriptase control in qRT-PCR experiments.
Endogenous IRGM detection by western blot
10610
6 HeLa or Huh 7.5 cells were treated with Smartpool si-
IRGM and control si-RNA were from Dharmacon. After mRNA
extraction as previously described 4 volumes of cold (220uC) acetone
was added to cell lysates and incubated for 60 min at 220uC. Solution
was centrifuged 20 min at 13,000 x g. Supernatant was discarded,
pellet was dried and ressupended in NuPage LDS sample buffer
(Invitrogen) with bond-breaker TCEP solution (Thermo Scientific).
MeV strain infection and titration
HeLa cells were infected with the MeV Edmonston strain 6 h
post-seeding at MOI of 3 for 24 or 48 hrs. Following 5 cycles of
freezing at 280uC and defrosting at 37uC total infectious particles
were quantified by limiting dilution on confluent Vero cells.
HCV strain infection and titration
Huh-7.5 cells were infected with HCV JFH1 strain 6 h post-
seeding at a MOI of 1. The level of virus particles present in
culture supernatants was determined by end-point dilution and
Core-specific immunofluorescence staining as described 24 or
48 hrs post-infection [49].
Influenza A strain, infection and titration
A549 cells were infected with influenza virus A/New Caledonia
(H1N1) at a MOI of 0.1. Cell supernatants were harvested at
24 hrs post-infection and samples were titrated by plaque assay
(PFU) in MDCK cells under agar overlay.
HIV-1 strain and infection
HIV-1 infections were performed with normalized amounts of
supernatants of R5 HIV-1-transfected cells. MDM were infected
with 250 mL of a viral solution containing 170 ng/mL p24 for
2 hrs at 37uC. Cells were then centrifuged during 5 minutes at
1200 rpm and the supernatant was removed. The cells were
cultured for 1 day in 1 mL of complete medium containing M-
CSF. Infection was followed by measuring HIV-1 gag p24 in the
supernatants of the infected cells using a p24 antigen capture
ELISA (Innogenetics).
Supporting Information
Figure S1 Interconnectivity distribution. The resampled
number of ppi between the 44 proteins of the autophagy network
(interconnectivity) was computed n=10.000 times based on a
random resampling procedure. The observed interconnectivity
inside the autophagy network (n=150) appears significantly
greater than the maximum number obtained after resampling.
Similar interconnectivity was observed excluding our own yeast
two-hybrid data set (n=123).***p,0.0001.
(TIF)
Figure S2 Autophagy-associated proteins contribute
differently to the autophagy network. Autophagy-associated
proteins are plotted according to their context connectivity (A), or
context centrality (B), corresponding to the x and y axis of the
Figure 2A, respectively.
(TIF)
Figure S3 Targeting of human autophagy network by
different RNA virus families. (A) Human autophagy network
targeted by proteins from the Paramyxoviridae family (MeV,
Mumps). (B) Flaviviridae (Kyasanur forest disease virus, HCV,
Tick-borne encephalitis virus. (C) Orthomyxoviridae (influenza A).
Each node represents one autophagy-associated protein. Black
nodes represent autophagy-associated proteins with unknown
RNA virus interactions and red nodes represent autophagy-
associated proteins targeted by at least oneviral protein from a
particular family. Blue edges represent novel ppi. Gray edges
represent ppi retrieved from the literature. The width of the nodes
is proportional to the degree of the proteins in the autophagy
network context, i.e. the number of autophagy-associated proteins
directly interacting with the considered protein.
(TIF)
Figure S4 Interaction of IRGM with RNA viruses
proteins. IRGM was tested by yeast two-hybrid against 83 viral
proteins from 5 different RNA virus families. Positive interactions
with proteins from viruses of the Paramyxoviridae, Flaviviridae,
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experiment representative of three is shown.
(TIF)
Figure S5 Endogenous ATG5 interacts with overex-
pressed IRGM. HeLa cells were transfected with 0.5 mgo f
expression vector encoding FLAG-SQSTM1 or FLAG-IRGM.
Cells were lysed and an affinity purification with an anti-FLAG
antibody was performed. A) Affinity purified samples (AP) and
total lysate were probed with an anti-ATG5 (A) or with and anti-
FLAG antibody (B).
(TIF)
Figure S6 Endogenous IRGM expression and si-IRGM
efficiency. (A) si-IRGM efficiency on exogenous eGFP IRGM
expression in HeLa, Huh7.5 and A549 cells. Cells were transfected
with 1.5 mg of expression vector encoding eGFP-IRGM and
simultaneously treated with control or IRGM specific si-RNAs for
48 hrs. Cells were lysed and analyzed by western-blot for the
expression of eGFP (top panel) and actin (bottom panel) detection.
(B) Anti-IRGM antibody recognition of Flag tagged IRGM. HeLa
cells were transfected with 0.5 mg of expression vector encoding
FLAG-IRGM and simultaneously treated with control or IRGM
specific si-RNAs for 24 hrs. Cells were lysed and analyzed by
western-blot for the expression of IRGM. (C) Full-length protein
gel with size markers showing endogenous IRGM expression in
Huh7.5 and A549 cells side to side with overexpressed IRGM
silenced by si-IRGM. (D) Huh7.5 cells treated with si-control or si-
IRGM. (E) si-IRGM efficiency on endogenous IRGM. HeLa and
Huh 7.5 cells were treated with control or IRGM si-RNAs for 24
hrs. Cells were lysed and analyzed by western-blot for IRGM (top
panel) and actin (bottom panel) detection. (F) si-IRGM efficiency
on endogenous IRGM mRNA. 10610
6 cells HeLa, Huh 7.5 and
A549 cells were treated with control or IRGM si-RNAs for 24 hrs.
Total RNA was extracted, mRNA was isolated and cDNA was
synthesized. IRGM mRNA was quantified with a quantitative
real-time polymerase chain reaction (qRT-PCR). The amount of
measured transcripts was normalized to the amount of the
Ribosomal protein S9 transcript. (G) Endogenous IRGM
expression (red) was assessed by immunofluorescence in HeLa
and Huh 7.5 cells treated with si-control or si-IRGM. Nuclei were
labelled with DRAQ5 (blue).
(TIF)
Figure S7 si-ATG5 efficiency. (A-B-C) si-ATG5 efficiency in
HeLa (A), Huh7.5 (B) and A549 (C) cells. Cells were treated with
control or ATG5 si-RNAs for 48 hrs and were either uninfected or
infected with MeV (MOI=3), HCV JFH-1 (MOI=1) or influenza
A/H1N1/New Caledonia (MOI=1) for 24 hrs. Cells were lysed
and analyzed by western-blot for the expression of ATG5 (top
panel) and actin (bottom panel) detection.
(TIF)
Figure S8 MeV, HCV and HIV-1-induced autophago-
some accumulation is dependent on IRGM. (A-B) MeV-
induced autophagy is dependent on IRGM. GFP-LC3-HeLa were
treated with si-control, si-ATG5 or si-IRGM and either left
uninfected or infected with MeV Edmonston (MOI=3) for 24 hrs.
Cells were treated with 100 nM bafilomycin during the last 5 hrs
of infection. Autophagy was monitored by evaluating the number
of GFP-LC3+ vesicles per cell profile by confocal microscopy.
Representative profiles for each condition (A) and the correspond-
ing graph representing the number of GFP-LC3+ vesicles per cell
profile (B) are shown, error bars, mean 6 SD of duplicates. One
experiment representative of three done in duplicate is shown. (C-
D) HCV-induced autophagosome accumulation is dependent on
IRGM. GFP-LC3-Huh7.5 were treated with si-control, si-ATG5
or si-IRGM and either left uninfected or infected with HCV JFH-
1 (MOI=1) for 24 hrs. Cells were treated with 100 nM
bafilomycin during infection. Autophagy was monitored by
evaluating the number of GFP-LC3+ vesicles per cell profile by
confocal microscopy. Representative profiles for each condition
(C) and the corresponding graph representing the number of GFP-
LC3+ vesicles per cell profile (D) are shown, error bars, mean 6
SD of duplicates. One experiment representative of three done in
duplicate is shown. (E-F) Influenza A-induced autophagosome
accumulation is not impaired by IRGM absence. GFP-LC3-A549
were treated with si-control, si-ATG5 or si-IRGM and either left
uninfected or infected with influenza A/H1N1/New Caledonia
(MOI=1) for 24 hrs. Cells were treated with 100 nM bafilomycin
during the last 5 hrs of infection. Autophagy was monitored by
evaluating the number of GFP-LC3+ vesicles per cell profile by
confocal microscopy. Representative profiles for each condition (E)
and the corresponding graph representing the number of GFP-
LC3+ vesicles per cell profile (F) are shown, error bars, mean 6
SD of duplicates. One experiment representative of three done in
duplicate is shown. (G) HIV-1-induced autophagosome accumu-
lation is dependent on IRGM. Monocyte-derived macrophages
(MDM) were treated with the indicated si-RNA and were either
left uninfected or infected with HIV-1 for 24 hrs. Cells were
treated with 100 nM bafilomycin during infection. Cells were lysed
and analyzed by western-blot for the detection of LC3-I and LC3-
II (top panel) and GADPH (bottom panel). One experiment
representative of three is shown with the quantification number
representing the intensity of LC3-II/GAPDH bands normalized to
the uninfected condition.
(TIF)
Figure S9 IRGM is located at the mitochondria. HeLa
cell cytosol or mitochondria fractions (Qproteome Mitochondria
Isolation Kit) were probed for the presence of IRGM, cytochrome
c or GAPDH.
(TIF)
Table S1 Autophay-associated proteins. 44 different
proteins were considered as autophagy-associated proteins based
on the PMID demonstrating protein role in autophagy (third
column of the table). The Ensembl gene identifier, official name,
synonym(s) and Ensembl description are indicated. Gene names
indicated in italic are the usual names found in the literature.
(XLS)
Table S2 Autophagy-asscociated proteins used in ex-
perimental work. Complete cDNA for 35 autophagy-associat-
ed proteins were purchased from several different providers
referenced in this table. Ensembl gene identifier, official name,
supplier and purchased vector are indicated.
(XLS)
Table S3 Viral proteins used in experimental work.
GenBank identifier of the viral proteins tested, ViralORFeome
clone identifier, viral strain, viral protein domain, virus, viral
family are indicated.
(XLS)
Table S4 Protein/protein interactions of virus/autoph-
agy-associated proteins by yeast two-hybrid array. Each
individual virus/autophagy-associated proteins ppi is represented
as an individual line of the table. For each interaction, the
autophagy-associated protein official name and Ensembl gene
identifier are indicated. GenBank identifier of the viral protein
involved in the interaction as well as the ViralORFeome clone
identifier, viral strain, viral protein domain, virus, viral family are
RNA Viruses Target the Autophagy Network
PLoS Pathogens | www.plospathogens.org 14 December 2011 | Volume 7 | Issue 12 | e1002422indicated under the same table line. The PMID of the interactions
found in the literature is indicated.
(XLS)
Table S5 Protein/protein interactions between autoph-
agy-associated proteins by yeast two-hybrid array. Each
individual ppi among autophagy-associated proteins is represented
as an individual line of the table. For each interaction, the two
autophagy-associated proteins involved are given with their official
names and Ensembl gene identifiers. The PMID of the
interactions found in the literature is indicated.
(XLS)
Table S6 Autophagy network metrics. For each of the
autophagy-associated proteins its official name and Ensembl gene
identifier, its degree in the human interactome, its adjusted
betweenness in the human interactome, its degree in the
autophagy network and its adjusted betweenness in the autoph-
agy-network are indicated.
(XLS)
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